Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse  John W. Sweetenham, MD, FRCP, Jan Walewski, MD, Auayporn Nadamanee, MD, Tamas Masszi, MD, PhD, Edward Agura, MD, Jerzy Holowiecki, MD, PhD, Muneer H. Abidi, MD, Andy I. Chen, MD, PhD, Pat Stiff, MD, Simonetta Viviani, Angelo Carella, MD, Dzhelil Osmanov, MD, Veronika Bachanova, MD, PhD, Anna Sureda, MD, PhD, Dirk Huebner, MD, Emily K. Larsen, MS, Naomi N. Hunder, MD, Craig H. Moskowitz, MD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S36-S37 (March 2016) DOI: 10.1016/j.bbmt.2015.11.315 Copyright © 2016 Terms and Conditions

Figure 1 PFS per Investigator. Biology of Blood and Marrow Transplantation 2016 22, S36-S37DOI: (10.1016/j.bbmt.2015.11.315) Copyright © 2016 Terms and Conditions